News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
24 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (8)
2 (81)
3 (24)
6 (132)
7 (216)
8 (201)
9 (223)
10 (129)
13 (236)
14 (204)
15 (97)
16 (109)
17 (66)
19 (3)
20 (31)
21 (142)
22 (117)
23 (165)
24 (70)
27 (156)
28 (137)
29 (116)
30 (191)
31 (92)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
3
6
7
8
9
10
13
14
15
16
17
19
20
21
22
23
24
27
28
29
30
31
Opinion
Why Is Novo Outperforming Lilly Despite Having Inferior GLP-1 Products?
Novo Nordisk’s GLP-1s outsell Eli Lilly’s thanks to its superior marketing. Here’s how.
January 3, 2025
·
6 min read
·
Gary Stibel
GLP-1
Lilly Asks to Join GLP-1 Compounding Lawsuit
Eli Lilly’s request to intervene in a suit filed by compounding pharmacies against the FDA reflects a belief the outcome could affect its business and that the FDA does not adequately represent its interests.
January 3, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 2, 2025
January 3, 2025
·
2 min read
Press Releases
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
January 3, 2025
·
7 min read
Press Releases
Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
January 3, 2025
·
1 min read
Press Releases
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
January 3, 2025
·
1 min read
Press Releases
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 3, 2025
·
1 min read
Press Releases
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
January 3, 2025
·
4 min read
Press Releases
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 3, 2025
·
1 min read
Press Releases
Therma Bright Announces Shares for Debt Issuance
January 3, 2025
·
2 min read
1 of 3
Next
